Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.08)
# 1,244
Out of 5,138 analysts
486
Total ratings
39.41%
Success rate
2.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVB Nuvation Bio | Maintains: Buy | $18 → $17 | $6.26 | +171.57% | 18 | Jan 12, 2026 | |
| HURA TuHURA Biosciences | Reiterates: Buy | $12 → $10 | $0.76 | +1,209.33% | 4 | Jan 9, 2026 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $26 → $27 | $10.64 | +153.76% | 4 | Jan 8, 2026 | |
| EXEL Exelixis | Maintains: Buy | $49 → $52 | $45.65 | +13.91% | 12 | Jan 8, 2026 | |
| COGT Cogent Biosciences | Maintains: Buy | $50 → $52 | $38.78 | +34.09% | 16 | Jan 6, 2026 | |
| TLX Telix Pharmaceuticals | Reiterates: Buy | $20 | $7.48 | +167.38% | 3 | Dec 22, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $28 → $31 | $18.96 | +63.50% | 20 | Dec 10, 2025 | |
| IMMX Immix Biopharma | Maintains: Buy | $8 → $12 | $4.74 | +153.16% | 10 | Dec 9, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $26 → $32 | $23.48 | +36.29% | 23 | Nov 18, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $19 → $23 | $11.31 | +103.45% | 26 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $136 → $140 | $106.42 | +31.55% | 46 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $144 | $7.97 | +1,706.78% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $121.90 | -40.11% | 21 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $9 | $1.57 | +475.08% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $1.74 | +14.94% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.06 | +371.70% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $2.57 | +16.73% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $7.05 | +70.21% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $6.58 | +6.38% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.63 | +92.84% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $6.60 | +127.27% | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.49 | +302.41% | 5 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.15 | +132.56% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $11.71 | +130.57% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $3.10 | +998.55% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $7.72 | +81.46% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $17.13 | +133.51% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $22.00 | +90.91% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.67 | +274.53% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.81 | +255.86% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $7.99 | +62.70% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $25.00 | +92.04% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $12.18 | +6.73% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.14 | +339.60% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.65 | +384.85% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.81 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $20.99 | +852.83% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.07 | +22,329.91% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.73 | +20,349.90% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.21 | +161.28% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $3.36 | +1,339,185.71% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.27 | +485.48% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.43 | +809.09% | 1 | Jan 7, 2021 |
Nuvation Bio
Jan 12, 2026
Maintains: Buy
Price Target: $18 → $17
Current: $6.26
Upside: +171.57%
TuHURA Biosciences
Jan 9, 2026
Reiterates: Buy
Price Target: $12 → $10
Current: $0.76
Upside: +1,209.33%
Cullinan Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $26 → $27
Current: $10.64
Upside: +153.76%
Exelixis
Jan 8, 2026
Maintains: Buy
Price Target: $49 → $52
Current: $45.65
Upside: +13.91%
Cogent Biosciences
Jan 6, 2026
Maintains: Buy
Price Target: $50 → $52
Current: $38.78
Upside: +34.09%
Telix Pharmaceuticals
Dec 22, 2025
Reiterates: Buy
Price Target: $20
Current: $7.48
Upside: +167.38%
Nurix Therapeutics
Dec 10, 2025
Maintains: Buy
Price Target: $28 → $31
Current: $18.96
Upside: +63.50%
Immix Biopharma
Dec 9, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $4.74
Upside: +153.16%
Zymeworks
Nov 18, 2025
Maintains: Buy
Price Target: $26 → $32
Current: $23.48
Upside: +36.29%
ORIC Pharmaceuticals
Nov 14, 2025
Maintains: Buy
Price Target: $19 → $23
Current: $11.31
Upside: +103.45%
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $106.42
Upside: +31.55%
Nov 7, 2025
Maintains: Buy
Price Target: $64 → $144
Current: $7.97
Upside: +1,706.78%
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $121.90
Upside: -40.11%
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.57
Upside: +475.08%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.74
Upside: +14.94%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
Oct 27, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $2.57
Upside: +16.73%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $7.05
Upside: +70.21%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $6.58
Upside: +6.38%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.63
Upside: +92.84%
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $6.60
Upside: +127.27%
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $2.49
Upside: +302.41%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $2.15
Upside: +132.56%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $11.71
Upside: +130.57%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $3.10
Upside: +998.55%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $7.72
Upside: +81.46%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $17.13
Upside: +133.51%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $22.00
Upside: +90.91%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.67
Upside: +274.53%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.81
Upside: +255.86%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $7.99
Upside: +62.70%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $25.00
Upside: +92.04%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $12.18
Upside: +6.73%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.14
Upside: +339.60%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.65
Upside: +384.85%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.81
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $20.99
Upside: +852.83%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.07
Upside: +22,329.91%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.73
Upside: +20,349.90%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.21
Upside: +161.28%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $3.36
Upside: +1,339,185.71%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.27
Upside: +485.48%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.43
Upside: +809.09%